Serum carnosinase deficiency: a non-disabling phenotype?
Serum carnosinase deficiency (McKusick 21220) is a rare condition, described in 13 cases. Ten additional individuals with serum carnosinase deficiency have been identified. All continued to excrete increased amounts of carnosine in their urine despite a meat-free diet for 3 days. Serum carnosinase activity ranged from 0-30% of normal. In four individuals a normal Km for carnosine of 0.12 mM was observed, while in five individuals an increased Km was found. Homocarnosine levels in CSF in three individuals ranged from 3.4 to 15 mM. Clinical symptoms in these individuals were as follows: attention deficit disorder: 4; non progressive developmental delay: 1; neurofibromatosis: 1; absences seizures: 1; severe, but non-progressive mental retardation, seizures and neurosensory hearing loss: 1; progressive childhood dementia; 1; clinically normal: 1. There was no correlation between severity and type of the neurological symptoms and residual serum carnosinase activity. Although a definite conclusion can only be made after a considerably higher number of individuals has been analyzed, the suspicion that serum carnosinase deficiency is unrelated to the neurological symptoms is strengthened by these observations. There may, however, be an association with a predisposition for mental deficiency.
D002336:Carnosine / Q000652:urine*; D002648:Child; D002675:Child, Preschool; D004150:Dipeptidases / Q000172:deficiency* / Q000235:genetics; D004151:Dipeptides / Q000652:urine*; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000201:enzymology* / Q000235:genetics; D007700:Kinetics; D008297:Male; D009154:Mutation; D010641:Phenotype
D004151:Dipeptides; D002336:Carnosine; D004150:Dipeptidases; C019673:aminoacyl-histidine dipeptidase